Clinical applications

Clinical Applications

Brainsigns, within its portfolio of services, offers also the possibility of assessing the impact that some drugs - as well as specific medical devices (e.g. the cochlear implants) - have on the Central Nervous System.

This is possible by evaluating the changes that occur in the cortical connectivity between different areas of the brain: in order to analyze the brain’s signals in response to the use of drugs and/or medical devices, Brainsigns’ methodologies are based on the measurement of the brain activity and of the cortical connectivity with the estimator ‘Partial Directed Coherence’.

Subscribe to this RSS feed
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok